Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

CURX

Curanex Pharmaceuticals Inc

Apr 30 • 11:22AM ET

0.4145

+0.0005 0.12 %

Healthcare • Biotechnology • USA • Nano • NASD

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.15	Insider Own	69.26%	Shs Outstand	28.34M	Perf Week	-6.45%
Market Cap	11.75M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	8.72M	Perf Month	-18.93%
Enterprise Value	7.13M	PEG	-	EPS next Q	-	Inst Own	1.50%	Short Float	0.58%	Perf Quarter	23.73%
Income	-4.23M	P/S	-	EPS this Y	-	Inst Trans	27.18%	Short Ratio	0.01	Perf Half Y	-45.50%
Sales	0.00M	P/B	1.05	EPS next Y	-	ROA	-69.85%	Short Interest	0.05M	Perf YTD	25.38%
Book/sh	0.40	P/C	2.37	EPS next 5Y	-	ROE	-72.09%	52W High	9.18 -95.48%	Perf Year	-
Cash/sh	0.18	P/FCF	-	EPS past 3/5Y	-1359.45% -	ROIC	-36.92%	52W Low	0.26 58.21%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	8.55% 11.86%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-1047.69%	Oper. Margin	-	ATR (14)	0.05	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	81.93	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	42.55	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	81.93	EPS Q/Q	-2112.24%	SMA20	-8.50%	Beta	-	Target Price	-
Payout	-	Debt/Eq	0.03	Sales Q/Q	-	SMA50	-4.92%	Rel Volume	0.01	Prev Close	0.41
Employees	-	LT Debt/Eq	0.02	Earnings	-	SMA200	-60.80%	Avg Volume	4.32M	Price	0.41
IPO	Aug 26, 2025	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	13,262	Change	0.12%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)